Eggplant Cures Cancer? Maybe Not

Dr. Bill Cham has a new book out called The Eggplant Cancer Cure; his website is EggplantCancerCure.com. According to the web site, "Dr. Cham has found substances which can penetrate and kill skin cancer cells but can’t penetrate normal skin cells, so normal skin cells are untouched and unhurt while the skin cancer cells die!" He claims to have conducted extensive studies on a cream he made (called Curaderm), which contains substances derived from eggplant. The cream is rubbed on skin cancer tumors (including late stage melanoma), and in a period of months, reduces the tumors and cures the cancer. He claims it has cured 70,000 skin cancer patients in Australia, and he's working on a way to make it work on internal tunors as well.



By the way, he isn't an M.D, he has a "Ph.D. in Medicine." It all sounds great, but there are some problems. He claims that the cream has been through Stage I, Stage II, stage III, and Stage IV clinical trials, but apparently, there isn't any published record of them. His website lists a bunch of publications supporting Curaderm, but some have titles like The Skin Cancer Cure So Effective, It's Being Kept Secret.



There's a nice critique of Cham and Curaderm from a blog called Respectful Insolence, which looks at a lot of cancer cure claims like this.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap